Journal Logo

You can read the full text of this article if you:

Institutional members access full text with Ovid®

CLINICAL REPORTS

Low-dose capecitabine plus docetaxel as first-line therapy for metastatic breast cancer: phase II results

Michalaki, Vasiliki; Gennatas, Spyridon; Gennatas, Konstantine

Author Information
doi: 10.1097/CAD.0b013e328327d492
  • Buy

Abstract

© 2009 Lippincott Williams & Wilkins, Inc.